Full Article: By: Rachel Hommel
https://innovation.ucsd.edu/2021/12/09/aim-awards-2022/
Accelerating Innovations to Market (AIM) Grants provide structured mentoring, resources, funding, and access to partners and investors to advance ideas from UC San Diego labs through feasibility projects and validation prototypes, and ultimately to scale.
This year’s awarded projects for the 2022 Accelerating Innovations to Market cycle showcased the breadth of UC San Diego’s research enterprise and diverse talent. We are proud to announce the 2022's recipients:
Digital Health System for Cost-Effective Glaucoma Screening, Management, and Surgical Intervention Through Artificial Intelligence
Investigators: Mark Christopher, Linda Zangwill, & Sally Baxter
[AIM]
Domain: Software-Based Healthcare Tech, A.I, Digital Platforms & Diagnostics
Glaucoma is a leading cause of blindness that affects more than 3 million people in the US and results in nearly $5 billion in annual costs. Glaucoma diagnosis and management is time-consuming, labor-intensive, and costly process. We have developed and validated a digital health system that enables early glaucoma detection and provides decision support for glaucoma managements. We are working to extend these tools to identify patients in need of surgical intervention and integrate them into clinical systems and workflows.
(858) 534-6290
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept